Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 versus POTASSIUM CHLORIDE 0 075 IN DEXTROSE 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 versus POTASSIUM CHLORIDE 0 075 IN DEXTROSE 5 IN PLASTIC CONTAINER.
CALCIUM CHLORIDE 10% vs POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium chloride dissociates to provide calcium ions, which are essential for myocardial contractility, nerve impulse transmission, and blood coagulation. It antagonizes the cardiotoxic effects of hyperkalemia by stabilizing cardiac cell membrane potential.
Potassium chloride dissociates to provide potassium ions, which are essential for maintaining intracellular fluid composition, nerve conduction, muscle contraction, and acid-base balance. Dextrose 5% provides a source of calories and water for hydration, with dextrose being metabolized to carbon dioxide and water, supplying energy.
IV: 500 mg to 1 g (5-10 mL of 10% solution) administered slowly at a rate not exceeding 0.5-1 mL/min; may be repeated every 1-3 days based on serum calcium levels.
Intravenous administration at a rate not exceeding 10 mEq/hour of potassium chloride; typical adult dose is 20-40 mEq per day administered as an additive to dextrose 5% solution, titrated to serum potassium levels.
None Documented
None Documented
Terminal half-life ~4-6 hours for rapid distribution phase; prolonged in renal impairment (up to 24-48 hours).
Potassium has a biphasic elimination: distribution half-life ~1 hour, terminal elimination half-life ~12 hours in normal renal function. Clinical context: Half-life extends significantly in renal impairment, requiring dose adjustment.
Primarily renal (>80% as ionized calcium); minor fecal elimination (10-20%) via endogenous secretion; negligible biliary excretion.
Potassium is primarily excreted renally (approximately 90%) via glomerular filtration and distal tubular secretion. Minor fecal elimination accounts for ~10%. Renal excretion is influenced by aldosterone, acid-base status, and potassium intake.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement